FDA Approved: IBRANCE — Original Application (U.S. Pharmaceuticals)

View source ↗

Summary

FDA approved IBRANCE (palbociclib) in its original application for HR-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women, in c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)

Snippet

ORIG AP for IBRANCE (PALBOCICLIB)